"Urticaria" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A vascular reaction of the skin characterized by erythema and wheal formation due to localized increase of vascular permeability. The causative mechanism may be allergy, infection, or stress.
| Descriptor ID |
D014581
|
| MeSH Number(s) |
C17.800.862.945 C20.543.480.904
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Urticaria".
Below are MeSH descriptors whose meaning is more specific than "Urticaria".
This graph shows the total number of publications written about "Urticaria" by people in this website by year, and whether "Urticaria" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 1998 | 1 | 0 | 1 |
| 2004 | 1 | 0 | 1 |
| 2006 | 1 | 1 | 2 |
| 2007 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2011 | 3 | 0 | 3 |
| 2013 | 1 | 0 | 1 |
| 2017 | 25 | 5 | 30 |
| 2018 | 42 | 4 | 46 |
| 2019 | 8 | 2 | 10 |
| 2020 | 14 | 5 | 19 |
| 2021 | 3 | 0 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Urticaria" by people in Profiles.
-
Safety of omalizumab treatment in patients with chronic spontaneous urticaria and COVID-19. Dermatol Ther. 2021 11; 34(6):e15111.
-
COVID-19 vaccine-induced urticarial vasculitis. Dermatol Ther. 2021 Sep; 34(5):e15093.
-
An infant with COVID-19 presenting with acute urticaria and angioedema. Int J Dermatol. 2021 Nov; 60(11):e471-e472.
-
Dermographism in COVID-19. BMJ Case Rep. 2021 Jun 23; 14(6).
-
Concomitant allergic contact dermatitis and aquagenic urticaria caused by personal protective equipment in a healthcare worker during the COVID-19 pandemic. Contact Dermatitis. 2021 10; 85(4):471-472.
-
[White dermographism as an atypical cutaneous manifestation of COVID-19]. Semergen. 2021 10; 47(7):e55-e56.
-
Cutaneous Manifestations of COVID-19: Characteristics, Pathogenesis, and the Role of Dermatology in the Pandemic. Cutis. 2021 Apr; 107(4):209-215.
-
Severe urticarial rash as the initial symptom of COVID-19 infection. BMJ Case Rep. 2021 Mar 25; 14(3).
-
SARS-CoV-2 spike protein positivity in pityriasis rosea-like and urticaria-like rashes of COVID-19. Br J Dermatol. 2021 06; 184(6):1194-1195.
-
Urticaria and coronavirus infection: a lesson from SARS-CoV-2 pandemic. Eur Ann Allergy Clin Immunol. 2021 03; 53(2):51-54.